jump to content jump to footer

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Research with mint mintLesion Clinical Research Standardized Reading Procedures iRECIST RECIST

Related Resources

Radiologist analyzing whole-body MRI scans of prostate cancer bone metastases using AI-assisted tumor load quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted tumor load quantification for bone metastases in prostate cancer with structured analysis, objective metrics, and longitudinal therapy assessment.
AI-Supported Tumor Load Quantification for Bone Metastasis in Prostate Cancer
To assess treatment response in patients with advanced prostate cancer, radiologists rely on advanced medical imaging. Conventional modalities, such…
Radiologists participating in a hands-on lung cancer screening workshop using structured reporting software mint Lesion at RÖKO 2026
Interactive hands-on workshop on lung cancer screening according to G-BA guidelines at RÖKO 2026, including structured reporting, double reading workflows, and consensus decision-making
Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026
Radiologist analyzing whole-body MRI scans of multiple myeloma using AI-assisted quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted quantification of bone involvement in multiple myeloma with structured analysis, objective metrics, and longitudinal disease tracking.
AI-Supported Quantification of Bone Involvement in Multiple Myeloma
Radiologists utilize Whole-Body MRI (WB-MRI) as an established imaging method for multiple myeloma staging [1,3]. Because it avoids ionizing…